{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:59:02Z","timestamp":1794239942572,"version":"4.9.0"},"reference-count":85,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Sentinel lymph node biopsy (SLNB) is a surgical procedure that has been used in patients with cutaneous melanoma for nearly 30 years. It is used for both staging and regional disease control with minimum morbidity, as proven by numerous worldwide prospective studies. It has been incorporated in the recommendations of national and professional guidelines. In this article, we provide a summary of the general information on SLNB in the clinical guidelines for the management of cutaneous malignant melanoma (American Association of Dermatology, European Society of Medical Oncology, National Comprehensive Cancer Network, and Cancer Council Australia) and review the most relevant literature to provide an update on the existing recommendations for SLNB.<\/jats:p>","DOI":"10.3390\/medicina58111589","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T04:00:51Z","timestamp":1667534451000},"page":"1589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View"],"prefix":"10.3390","volume":"58","author":[{"given":"Daciana Elena","family":"Br\u0103ni\u015fteanu","sequence":"first","affiliation":[{"name":"Department Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Railway Clinical Hospital, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Cozmin","sequence":"additional","affiliation":[{"name":"Clinical Department, \u201cApollonia\u201d University of Iasi, 700511 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-2066","authenticated-orcid":false,"given":"Elena","family":"Porumb-Andrese","sequence":"additional","affiliation":[{"name":"Department Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Railway Clinical Hospital, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Br\u0103ni\u015fteanu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-836X","authenticated-orcid":false,"given":"Mihaela Paula","family":"Toader","sequence":"additional","affiliation":[{"name":"Department Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Railway Clinical Hospital, 700506 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Iosep","sequence":"additional","affiliation":[{"name":"Department Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sinigur","sequence":"additional","affiliation":[{"name":"Department Dermatology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lina Ioana","family":"Br\u0103ni\u015fteanu","sequence":"additional","affiliation":[{"name":"\u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Br\u0103ni\u015fteanu","sequence":"additional","affiliation":[{"name":"\u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-4857","authenticated-orcid":false,"given":"Vlad","family":"Porumb","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-1662","authenticated-orcid":false,"given":"Alin Constantin","family":"P\u00eenzariu","sequence":"additional","affiliation":[{"name":"Department of Morpho-Functional Sciences II, Discipline of Physiology, \u2018Grigore T. Popa\u2019 University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin Liviu","family":"B\u0103il\u0103","sequence":"additional","affiliation":[{"name":"Vascular Surgery Group, Ponderas Academic Hospital, 014142 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-464X","authenticated-orcid":false,"given":"Alin Codru\u021b","family":"Nicolescu","sequence":"additional","affiliation":[{"name":"Roma Medical Center for Diagnosis and Treatment, 011773 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fsc.2018.08.001","article-title":"Nonmelanoma Skin Cancer","volume":"27","author":"Brandt","year":"2019","journal-title":"Facial. Plast. Surg. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.hoc.2020.08.011","article-title":"Epidemiology of Melanoma","volume":"35","author":"Bolick","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","article-title":"Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment","volume":"30","author":"Ahmed","year":"2020","journal-title":"Crit. Rev. Eukaryot. Gene. Expr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., and Barsouk, A. (2021). Epidemiology of Melanoma. Med. Sci., 9.","DOI":"10.3390\/medsci9040063"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early-stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1097\/RLU.0000000000001370","article-title":"Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature","volume":"41","author":"Tardelli","year":"2016","journal-title":"Clin. Nucl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10585-021-10089-9","article-title":"Sentinel lymph node biopsy in melanoma: Beyond histologic factors","volume":"39","author":"Carr","year":"2022","journal-title":"Clin. Exp. Metastasis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Morton, D.L., Thompson, J.F., Essner, R., Elashoff, R., Stern, S.L., Nieweg, O.E., Roses, D.F., Karakousis, C.P., Mozzillo, N., and Reintgen, D. (1999). Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann. Surg., 230.","DOI":"10.1097\/00000658-199910000-00001"},{"key":"ref_9","first-page":"331","article-title":"Surgical procedures in melanoma: Recommended deep and lateral margins, indications for sentinel lymph node biopsy, and complete lymph node dissection","volume":"156","author":"Nagore","year":"2021","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"MSLT Group. Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"American Society of Clinical Oncology; Society of Surgical Oncology. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1007\/s00259-015-3135-1","article-title":"EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma","volume":"42","author":"Bluemel","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.suc.2019.09.002","article-title":"Surgical Management of Lymph Nodes in Melanoma","volume":"100","author":"Heller","year":"2020","journal-title":"Surg. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.6004\/jnccn.2021.0018","article-title":"NCCN Guidelines\u00ae Insights: Melanoma: Cutaneous, Version 2.2021","volume":"19","author":"Swetter","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Morton, D.L., Cochran, A.J., Thompson, J.F., Elashoff, R., Essner, R., Glass, E.C., Mozzillo, N., Nieweg, O.E., Roses, D.F., and Hoekstra, H.J. (2005). Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann. Surg., 242.","DOI":"10.1097\/01.sla.0000181092.50141.fa"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1245\/s10434-021-10570-5","article-title":"Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection","volume":"28","author":"Broman","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMe1313690","article-title":"Clinical Value of the Sentinel-Node Biopsy in Primary Cutaneous Melanoma","volume":"370","author":"Balch","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1245\/s10434-014-3954-5","article-title":"The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma","volume":"21","author":"Kachare","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10434-001-0538-y","article-title":"The definition of a sentinel node","volume":"8","author":"Nieweg","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","article-title":"The orderly progression of melanoma nodal metastases","volume":"220","author":"Reintgen","year":"1994","journal-title":"Ann. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-199508000-00008","article-title":"Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes","volume":"5","author":"Thompson","year":"1995","journal-title":"Melanoma. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/j.1098-2388.1993.tb00011.x","article-title":"Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma","volume":"9","author":"Ross","year":"1993","journal-title":"Semin. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: Comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_28","first-page":"948","article-title":"A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma","volume":"41","author":"Sim","year":"1978","journal-title":"Preliminary results. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","article-title":"Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities","volume":"49","author":"Veronesi","year":"1982","journal-title":"Cancer"},{"key":"ref_30","first-page":"105","article-title":"A critical reappraisal of false negative sentinel lymph node biopsy in melanoma","volume":"58","author":"Manca","year":"2014","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/RLU.0000000000000366","article-title":"Sentinel lymph node mapping in melanoma: The issue of false-negative findings","volume":"39","author":"Manca","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1245\/s10434-016-5175-6","article-title":"SPECT\/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma","volume":"23","author":"Chapman","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1245\/s10434-011-2031-6","article-title":"The additional value of lymphatic mapping with routine SPECT\/CT in unselected patients with clinically localized melanoma","volume":"19","author":"Veenstra","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/2012.jama.11030","article-title":"Association between sentinel lymph node excision with or without preoperative SPECT\/CT and metastatic node detection and disease-free survival in melanoma","volume":"308","author":"Stoffels","year":"2012","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.amjsurg.2010.01.019","article-title":"Sentinel lymph node staging of cutaneous melanoma: Predictors and outcomes","volume":"199","author":"Ellis","year":"2010","journal-title":"Am. J. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","article-title":"Observation after a positive sentinel lymph node biopsy in patients with melanoma","volume":"21","author":"Bamboat","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11845-017-1559-2","article-title":"Analysis of sentinel node positivity in primary cutaneous melanoma: An 8-year single institution experience","volume":"186","author":"Joyce","year":"2017","journal-title":"Ir. J. Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12687","article-title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: A critical appraisal and comprehensive review","volume":"170","author":"Fong","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_40","unstructured":"Thompson, J.F., Cancer Council Australia, Australian Cancer Network, and New Zealand, Ministry of Health (2008). Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand, Cancer Council Australia. Available online: https:\/\/www.cancer.org.au\/health-professionals\/clinical-practice-guidelines."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1200\/JCO.2005.04.0147","article-title":"Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial","volume":"23","author":"Thomas","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaad.2009.08.063","article-title":"Sentinel node biopsy and standard of care for melanoma: A re-evaluation of the evidence","volume":"62","author":"Kanzler","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.22382","article-title":"The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma","volume":"109","author":"Paek","year":"2007","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1245\/s10434-014-3641-6","article-title":"Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor","volume":"21","author":"Mitteldorf","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","article-title":"Association Between Patient Age and Lymph Node Positivity in Thin Melanoma","volume":"153","author":"Sinnamon","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jso.24743","article-title":"Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma","volume":"116","author":"Sinnamon","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"German Dermatologic Cooperative Oncology Group (DeCOG). Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/abd1806-4841.20187312","article-title":"Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: A critical review","volume":"93","author":"Eiger","year":"2018","journal-title":"An. Bras. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1245\/s10434-019-07830-w","article-title":"The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes)","volume":"27","author":"Bello","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ncponc1205","article-title":"The rationale for sentinel-node biopsy in primary melanoma","volume":"5","author":"Morton","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.surg.2006.12.018","article-title":"Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy","volume":"141","author":"Sabel","year":"2007","journal-title":"Surgery"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2004.09.005","article-title":"Radiation therapy following lymph node dissection in melanoma patients: Treatment, outcome and complications","volume":"31","author":"Bastiaannet","year":"2005","journal-title":"Cancer Treat. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1470-2045(01)00519-8","article-title":"Lymph-node metastases in patients with melanoma: What is the optimum management?","volume":"2","author":"Fife","year":"2001","journal-title":"Lancet. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/S1470-2045(19)30099-3","article-title":"The extent of surgery for stage III melanoma: How much is appropriate?","volume":"20","author":"Franke","year":"2019","journal-title":"Lancet. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jso.25316","article-title":"Current management of regional lymph nodes in patients with melanoma","volume":"119","author":"Bartlett","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PRS.0000000000004395","article-title":"Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis","volume":"141","author":"Appleton","year":"2018","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2018.08.051","article-title":"Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database","volume":"80","author":"Conic","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1245\/s10434-016-5137-z","article-title":"Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis","volume":"23","author":"Cordeiro","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jso.25208","article-title":"Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts","volume":"118","author":"Isaksson","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejso.2018.11.022","article-title":"Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases","volume":"45","author":"Piazzalunga","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1002\/cam4.2358","article-title":"Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study","volume":"8","author":"Ribero","year":"2019","journal-title":"Cancer Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2015.09.014","article-title":"A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas","volume":"74","author":"Wat","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jamcollsurg.2018.12.030","article-title":"Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System?","volume":"228","author":"Egger","year":"2019","journal-title":"J. Am. Coll. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejso.2019.09.189","article-title":"Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma","volume":"46","author":"Boada","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/cncr.29239","article-title":"Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma","volume":"121","author":"Yamamoto","year":"2015","journal-title":"Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1245\/s10434-015-4894-4","article-title":"Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool","volume":"23","author":"Gyorki","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/jdv.14485","article-title":"Is mitotic rate still useful in the management of patients with thin melanoma?","volume":"31","author":"Gallego","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update","volume":"36","author":"Wong","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bjps.2019.06.020","article-title":"Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement","volume":"73","author":"Peach","year":"2020","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annder.2019.01.011","article-title":"Actualisation des donn\u00e9es concernant le m\u00e9lanome stade III: Nouvelles recommandations du groupe fran\u00e7ais de canc\u00e9rologie cutan\u00e9e [New guidelines for stage III melanoma (the French Cutaneous Oncology Group)]","volume":"146","author":"Guillot","year":"2019","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.23736\/S0392-0488.19.06383-1","article-title":"Management of cutaneous melanoma: Comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology","volume":"155","author":"Argenziano","year":"2020","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_73","first-page":"464","article-title":"Dermatologists across Europe underestimate depression and anxiety: Results from 3635 dermato-logical consultations","volume":"179","author":"Dalgard","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PSY.0000000000000942","article-title":"Major Depression and Survival in People with Cancer","volume":"83","author":"Walker","year":"2021","journal-title":"Psychosom. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11764-020-00885-9","article-title":"Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: A 4- year longitudinal study","volume":"14","author":"Beesley","year":"2020","journal-title":"J. Cancer Surviv."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1245\/s10434-008-0077-x","article-title":"Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma","volume":"15","author":"Canteras","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11845-014-1166-4","article-title":"Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population","volume":"184","author":"Woods","year":"2015","journal-title":"Ir. J. Med. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1200\/JCO.20.01121","article-title":"Improved Tool for Predicting Sentinel Lymph Node Metastases in Melanoma","volume":"38","author":"Faries","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jso.25720","article-title":"A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making","volume":"120","author":"Friedman","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.19.01902","article-title":"Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram","volume":"38","author":"Maurichi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_81","first-page":"577","article-title":"Prediction of sentinel lymph node positivity by growth rate of cutaneous melanoma","volume":"148","author":"Nagore","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.15311","article-title":"Prevalence and determinants of sunbed use in thirty European countries: Data from the Euromelanoma skin cancer prevention campaign","volume":"33","author":"Suppa","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/PO.19.00206","article-title":"Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma","volume":"4","author":"Bellomo","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"842496","DOI":"10.3389\/fonc.2022.842496","article-title":"Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship","volume":"12","author":"Slominski","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/pcmr.12890","article-title":"Speed rate (SR) as a new dynamic index of melanoma behavior","volume":"33","author":"Gualdi","year":"2020","journal-title":"Pigment. Cell Melanoma. Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/11\/1589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:59Z","timestamp":1760144999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/11\/1589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":85,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["medicina58111589"],"URL":"https:\/\/doi.org\/10.3390\/medicina58111589","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}